JStar Capital Investments is a healthcare investment firm based in the United States, focusing on the med-tech sector. With over $100 million in capital, it targets late-stage healthcare companies poised for monetization or strategic exit.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
JStar Capital Investments is an investment organization founded to focus on the med-tech healthcare sector. The organization is based in the United States and has over $100 million in capital affiliation. JStar Capital aims to reshape the healthcare landscape through strategic investments and clinical insights, focusing on innovative medical technologies. The firm specializes in investing in breakthrough medical technologies and services across several sectors, including cardiovascular and stroke protection, orthopedic technologies, and biopharma innovative solutions. JStar Capital's portfolio includes notable companies such as Sonavex, Adhere Plus, and Zetagen, demonstrating its commitment to supporting promising medical technology ventures.
JStar Capital specializes in breakthrough medical technologies and services, particularly in cardiovascular and stroke protection, orthopedic technologies, biopharma solutions, and digital health innovations. The organization targets late-stage companies that demonstrate clinical validation and a clear path to scalable adoption.
JStar Capital provides strategic support to portfolio companies by leveraging its network of healthcare and financial experts. The firm emphasizes clinical depth, commercial intelligence, and capital efficiency, helping companies navigate regulatory, reimbursement, and adoption pathways.
JStar Capital focuses on late-stage healthcare companies that demonstrate clinical validation and a clear path to scalable adoption. They prioritize innovations that improve patient outcomes and lower costs.
Founders can pitch JStar Capital through their website at jstarinvestments.com. It is advisable to include detailed information about the company's clinical validation and commercialization strategy in the pitch.
JStar Capital combines capital with clinical insights, leveraging a network of healthcare and financial experts to assist portfolio companies in navigating regulatory and reimbursement challenges.
The firm primarily invests in the United States, focusing on healthcare and biotech sectors.
Specific check sizes are not publicly disclosed, but JStar Capital is known for making significant investments in late-stage companies.
JStar Capital provides strategic support to its portfolio companies, helping them navigate the complexities of healthcare delivery and commercialization.
Organizations that do similar work to JStar Capital Investments.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorOrbiMed is a healthcare-focused investment firm based in New York City, managing approximately $19 billion in assets. The firm invests across the healthcare spectrum, from early-stage startups to large multinational companies, with a focus on biopharmaceuticals and medical technologies.
InvestorLongeVC is a venture capital firm based in Washington D.C. that invests in early-stage biotechnology and longevity-focused companies. They aim to support founders in bringing innovative biotech solutions to market.
Superscout Pro
Is this page right?Reviewed · How the research works